Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Interpol Seizes Counterfeit Drugs In Southeast Asia; More Measures Mulled

This article was originally published in PharmAsia News

Executive Summary

The International Criminal Police Organization confiscated $6.65 million worth of counterfeit HIV/AIDS, malaria and tuberculosis drugs in Southeast Asia, the organization announced at the International Law Enforcement Training Seminar on Combating Counterfeit Drugs Nov. 17 in Phnom Penh, Cambodia

You may also be interested in...



Latest Operation Pangea Prompts Asian Crackdowns

As part of the annual global Operation Pangea, coordinated by Interpol to crack down on counterfeit drugs and illicit online sales of medicines and medical devices, South Korea's Ministry of Food and Drug Safety has uncovered more than 800 websites that illegally sell medicines to consumers, while other Asian authorities are also taking action.

Malaysia Steps Up Surveillance Of Counterfeit Drugs

SHANGHAI - The Malaysian Padang Besar Anti-Smuggling Unit seized 12,285 bottles of China-made herb capsules and Chinese medicine at the Malaysian-Thai border in early December, the authorities announced recently

Malaysia Steps Up Surveillance Of Counterfeit Drugs

SHANGHAI - The Malaysian Padang Besar Anti-Smuggling Unit seized 12,285 bottles of China-made herb capsules and Chinese medicine at the Malaysian-Thai border in early December, the authorities announced recently

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067593

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel